In the current study, we show that the altered signaling induced by PTP1B expression, which includes aberrant canonical Wnt/β-catenin and Src/Erk signaling culminates in an enhancement of CRC metastatic potential by increasing proliferation, migrational activity, and anoikis resistance in these cells. This evidence concerns the gene PTPN1 and colorectal carcinoma.